SynBiotic SE

Equities

SBX

DE000A3E5A59

Pharmaceuticals

End-of-day quote BOERSE DUESSELDORF 06:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
9.2 EUR -9.36% Intraday chart for SynBiotic SE -8.00% +207.69%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
SynBiotic Boosts CBD Business with Ilesol Pharmaceuticals Takeover MT
SynBiotic SE acquired Ilesol Pharmaceuticals d.o.o. za proizvodnju i usluge. CI
Cannabis law signed - release on April 1 DP
Controversial cannabis law has been signed DP
TOTAL Federal Council paves the way for growth package and cannabis DP
Federal Council clears the way for cannabis legalization DP
Synbiotic continues to rise after cannabis legalization DP
Circles/Cannabis dispute: Hesse wants to abstain in the Bundesrat DP
Cannabis dispute: Baden-Württemberg in favor of mediation committee DP
Synbiotic corrects after cannabis rally - legalization open DP
Daniel Günther: Cannabis law to be postponed until October DP
Cannabis dispute: Baden-Württemberg calls for mediation committee DP
Cannabis law and clinic atlas in the Bundesrat DP
Dreyer does not expect cannabis law to fail DP
Drugs commissioner lobbies states for cannabis law DP
Union interior ministers want to consider legal action against cannabis legalization DP
Synbiotic share price fireworks continue - cannabis approval imminent DP
Juvenile court judge Müller warns against scaremongering on cannabis DP
SHARES IN FOCUS 2: Synbiotic and Cantourage rally - risk of correction feared DP
SHARES FOCUS: Cannabis legalization drives Synbiotic and Cantourage upwards DP
Drugs commissioner urges implementation of cannabis release DP
SynBiotic SE Reports Earnings Results for the Full Year Ended December 31, 2022 CI
SynBiotic Buys CannaCare Health, WellHealth; New CEO Named MT
SynBiotic SE announced that it has received ?3 million in funding CI
SynBiotic SE acquired CannaCare Health GmbH. CI
Chart SynBiotic SE
More charts
SynBiotic SE is a Germany-based investment company. Mainly the Company invests in cannabinoid focused ventures and teams.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
9.12 EUR
Average target price
15.2 EUR
Spread / Average Target
+66.67%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SBX Stock
  4. News SynBiotic SE
  5. SynBiotic : Germany-listed Cannabis Company SynBiotic Plans Canadian NEO Exchange Float